Proactive Equities
Empowering investors with insights, analysis and expert recommendations to navigate financial markets with confidence.
Acrow Limited (ASX: ACF): Is This Growing Equipment Rental Business a Buy in Oversold Territory?
Mar 15, 2026 | Proactive Equities Team
New Murchison Gold (ASX: NMG): Pay for the Current Gold, Get the Exploration Potential for Free
Mar 14, 2026 | Proactive Equities Team
These ASX stocks give you exposure to the rising interest in defence spending
Mar 14, 2026 | Proactive Equities Team
New Murchison Gold (ASX: NMG): Pay for the Current Gold, Get the Exploration Potential for Free
New Murchison Gold Limited is a small Australian gold producer operating the Crown Prince mine in Western Australia. The company recently transitioned from exploration to production and is generating strong cash flow from high-grade ore sold to Westgold Resources Limited. Exploration at nearby targets and potential underground mining could extend the project’s life and add future growth potential.
Electro Optic Systems (ASX: EOS): Pricing the Counter-Drone and Laser Defence Opportunity
Electro Optic Systems develops remote weapon systems, counter-drone platforms and laser defence technologies for military customers. Despite strong order-book growth and rising defence demand, the company still generates operating losses and negative cash flow. Its valuation is largely based on future growth in counter-drone and directed-energy defence systems.
Racura Oncology Ltd (ASX: RAC): Could RC220 Turn This Small Biotech into a Billion-Dollar Cancer Stock?
Racura Oncology is a clinical-stage biotech developing RC220 (bisantrene), a potential treatment for cancers such as AML and lung cancer. The company is pre-revenue and mainly funded through cash reserves and capital raises while advancing clinical trials. Its future valuation depends largely on trial results, regulatory progress and potential partnerships if the drug proves effective.
Has Telix Pharmaceutical's (ASX: TLX) share price reached the bottom?
Telix Pharmaceuticals is a radiopharmaceutical company focused on cancer imaging and therapies, with strong revenue growth driven by products like Illuccix and Gozellix. While recent gains suggest the stock may be stabilising, future performance will depend on continued commercial growth and pipeline progress.
How much higher can Lynas Rare Earths (ASX: LYC) share price go?
Lynas Rare Earths is the largest rare earth producer outside China, supplying critical magnet materials used in EVs, renewable energy and defence technologies. Its core Mt Weld mine and expanding processing facilities position the company as a key player in the Western rare earth supply chain. While earnings remain highly sensitive to rare earth prices, ongoing capacity expansion and stronger NdPr demand could support significant long-term growth.
Mineral Resources (ASX: MIN): An undervalued ASX miner facing an important resistance level
Mineral Resources is emerging from a heavy investment phase as the Onslow Iron project reaches scale, driving a sharp recovery in earnings and cash flow. With iron ore production ramped up and lithium assets backed by a major POSCO partnership, the business is now showing the financial benefits of years of expansion. Despite the turnaround, the stock still appears undervalued relative to its long‑term earnings, cash‑flow potential, and asset base.
TechnologyOne (ASX: TNE): A Defensive SaaS Compounder with Premium Valuation
TechnologyOne is a leading Australian SaaS provider delivering cloud ERP software to governments and large organisations. Its recurring revenue model supports strong margins and steady growth. However, the stock trades at a premium valuation, leaving little margin for growth disappointments.
Paladin Energy (ASX: PDN): A Leveraged Play on the Uranium Price Recovery
Paladin Energy is a leveraged uranium producer centred on the restarted Langer Heinrich mine in Namibia. Its earnings are highly sensitive to uranium prices, making the stock a direct play on the nuclear fuel cycle. Future growth could come from the large Patterson Lake South project in Canada.
Immutep (ASX: IMM): A High-Risk Immunotherapy Bet Waiting for Phase III Validation
Immutep is a Sydney-based clinical-stage biotechnology company focused on immunotherapy, specifically targeting the LAG-3 immune pathway. The company is dual-listed on the ASX and NASDAQ, giving it access to both Australian and US capital markets. It does not yet generate commercial product revenue and remains dependent on capital markets and partnerships to fund its development programs, making it a milestone-driven investment rather than a revenue-backed operating business.
Has Neuren Pharmaceuticals' (NEU) share price bottomed out?
If you bought Neuren Pharmaceuticals (ASX: NEU) near its peak, the recent volatility has been uncomfortable. Despite having its first approved drug for a rare paediatric disorder, growing royalty income and a promising pipeline, the share price has repeatedly rallied and retraced over the past two years. The key question now is whether NEU has already formed a durable bottom — or if another leg down could still test investor conviction.
Acrow Limited (ASX: ACF): Is This Growing Equipment Rental Business a Buy in Oversold Territory?
Acrow Limited is an Australian engineering and equipment rental company supplying formwork and scaffolding to construction and infrastructure projects. The business generates recurring income from its large hire fleet and has delivered strong revenue growth in recent years. Despite recent share price weakness, it offers solid cash flow and a fully franked dividend yield above 5%.
Is it a good time to buy NRW Holdings (ASX: NWH) after the bounce off its major support level?
NRW Holdings is an Australian mining services contractor providing civil construction and contract mining to major producers like BHP and Rio Tinto. Its earnings are closely tied to Australia’s mining investment cycle. Strong cash flow and new contracts could support recovery if resource sector capex remains strong.
Beach Energy (ASX: BPT): Undervalued Gas Producer with Growth Potential
Beach Energy is a gas-focused Australian producer supplying the domestic east coast market, with most output coming from the Cooper, Otway and Perth basins. The key growth driver is the Waitsia Gas Project, which could lift production and cash flow as it ramps up. The stock offers a high fully franked dividend but remains sensitive to energy prices and project execution.
Yancoal Australia (ASX: YAL): Strong Cash Flow, Zero Debt, and Leverage to Coal Prices
Yancoal Australia is largely a pure play on global coal prices, with profits rising and falling almost directly with commodity cycles. The company has dramatically strengthened its balance sheet, eliminating over $3bn of debt and building more than $2bn in cash, giving it one of the most conservative capital structures among coal producers. Even after coal prices normalised, low operating costs allow the business to remain profitable with solid cash flow and sustainable production levels.
Monadelphous Group (ASX: MND) – From Turnaround Story to Premium-Cycle Pricing
Monadelphous Group is a high-quality, cycle-exposed engineering contractor leveraged to Australian resources and energy capex. Strong cash generation, a net cash balance sheet and disciplined contract selection underpin its reputation and dividend capacity. Long-standing Tier 1 client relationships support earnings resilience across mining, LNG and infrastructure projects. However, the current valuation suggests much of the favourable operating outlook is already priced in.
Fortescue Ltd (ASX: FMG): Strong Cash Flows and Dividends in a Cyclical Iron Ore Market
Fortescue Ltd is a low-cost iron ore producer with strong cash flow and attractive fully franked dividends, but earnings remain highly exposed to iron ore prices and Chinese demand. Trading around mid-cycle valuation levels, the stock looks fairly valued, with upside dependent on stronger commodity prices and successful expansion into magnetite and green energy.
Westpac Banking Corporation (ASX: WBC) – Capital Strength and Dividend Appeal in a Low-Growth Environment
Westpac Banking Corporation is a systemically important bank with a strong mortgage franchise, solid capital buffers and a fully franked dividend. With modest 3–4% earnings growth expected, current valuations look full, making it more suited to income investors than deep-value buyers.
Ansell Limited (ASX: ANN) – Margin Recovery and Attractive Long-Term Support Zone
We argue that despite cyclical and integration risks, Ansell’s improving margins and disciplined capital execution support a stable medium-term outlook. Technically and fundamentally, the A$28–30 range appears to represent a key support zone and a potentially attractive long-term entry level, provided earnings stability is maintained.
BlueScope Steel (ASX: BSL): An Australian Industrial with U.S. Earnings Power
BlueScope is an integrated flat steel producer combining upstream steelmaking with higher‑margin, branded building products, giving it resilience across cycles. Around half of earnings are leveraged to the U.S. through North Star, where profitability depends on steel‑to‑scrap spreads rather than iron ore, providing structural margin support. In 1H FY2026, BlueScope delivered strong earnings growth despite weak HRC prices, driven by disciplined cost control and solid North American performance, underscoring its leverage to U.S. construction activity rather than pure commodity steel cycles.
Bega Group (ASX: BGA): A Turning Point After a Decade of Capital Expansion
Bega Group has evolved from a regional dairy co-operative into a diversified branded food business spanning cheese, spreads and milk beverages, combining defensive staple demand with branded exposure. The investment case now hinges on whether recent operational improvements can translate scale and strong household brands into sustained margin and ROIC expansion. However, with limited product innovation and rising marketing spend largely aimed at defending shelf space, the company’s growth profile remains more defensive than structurally transformative.
These ASX stocks give you exposure to the rising interest in defence spending
Rising geopolitical tensions and military modernisation are driving a surge in global defence spending, which exceeded US$2.6 trillion in 2025. Australia is also increasing defence investment, with spending expected to approach A$100 billion by 2034. As a result, ASX-listed companies involved in defence technology, shipbuilding and security systems are gaining investor attention as part of a long-term growth trend.
Which companies on the ASX will benefit the most from the soaring oil and gas prices?
Geopolitical tensions and supply disruptions have pushed global oil and gas prices higher. When benchmarks rise, ASX energy producers—especially upstream and LNG exporters—often see stronger revenues and margins due to robust demand from Asian markets.
.webp&w=828&q=75)
Macroeconomic Report for the Week Ending 6 February 2026 – Australian Market Outlook
Markets faced a “soft-landing but sticky” backdrop: growth held up, yet inflation and policy uncertainty kept risk elevated and dispersion high. The US stayed resilient but uneven as labour demand cooled and the Fed remained cautious. The ECB stayed meeting-by-meeting. Australia felt higher-for-longer, rotating into defensives.
Can the recent rally in nickel prices last, and where can one get exposure on the ASX?
Global nickel prices have surged to near US$18,000 per tonne on supply concerns, particularly around potential production cuts in Indonesia and regulatory uncertainty. The rally has been amplified by speculative flows and broader base-metals momentum, despite elevated inventories and mixed demand fundamentals.
Zinc prices are quietly rising - which ASX stocks can benefit the most?
Zinc prices are edging higher as physical markets tighten, supported by steady demand from steel, infrastructure and renewable energy projects alongside shrinking exchange inventories, particularly on the LME. With supply growth limited and visibility low, declining stocks are increasing concerns around future availability, which can underpin higher prices. For ASX investors, this environment favours zinc-exposed producers, developers and explorers, as well as diversified miners with meaningful base-metal exposure, all of which stand to benefit from improving project economics and margins as zinc’s outlook strengthens.
The reason tin prices are rising and 3 ASX stocks that provide the best exposure
Tin prices have been climbing sharply because the metal is suddenly caught between rising demand and tightening supply. Electronic devices, artificial intelligence hardware, solar panels and electric vehicles all rely on tin-based solder and components, pushing consumption higher just as long-neglected supply struggles to keep up. Production has been disrupted in key regions by political instability, mine closures and regulatory crackdowns, and underinvestment means new sources aren’t coming online fast enough. In this article we discuss some of the ASX stocks that can benefit the most from the rising tin prices.
Why silver prices keep soaring, and how you can benefit from it on the ASX?
Silver has quietly moved into a powerful uptrend, and it’s not happening by accident. The metal is being pulled in two directions at once, as a financial haven and as an industrial workhorse. For ASX investors, this creates an opportunity. Exposure comes through producers, developers, and explorers whose revenues and valuations tend to rise as silver prices strengthen, offering leverage to a market driven by both fear and future-focused demand.
Macroeconomic Report for the Week Ending 5 December 2025 – Australian Market Outlook
Global data point to a softening but still mixed growth backdrop, with US manufacturing in mild contraction contrasted against resilient services activity. Labour indicators such as ADP employment and continuing jobless claims show cooling private hiring and more challenging re‑employment conditions, reinforcing expectations of earlier and deeper Federal Reserve rate cuts. Core US PCE inflation is running at a steady, moderate pace, allowing the Fed to stay on hold while waiting for clearer evidence that inflation is durably converging to the target.
3 ASX Stocks with Bullish Charts
When you spend enough time around the ASX, you start to notice a certain rhythm in how strong charts behave. Some stocks creep for weeks, building energy in tight ranges, and then, almost without announcement, they begin flashing early signs of strength. In this review, we focus on three ASX-listed companies whose price action suggests further upside.
Lithium Price Is on the Rise. Which ASX Lithium Stocks Offer Better Opportunities?
Lithium prices are rising again, which tends to lift investor interest in ASX-listed producers. Thanks to growing demand for batteries (EVs, energy storage) and tightening supply, analysts suggest the recent price upswing, roughly 20–25% month-on-month, may mark a turning point. In that context, some ASX companies with solid operations and cash flow stand out as offering relatively better risk-adjusted opportunities. Still, it’s not a guaranteed path: lithium remains a volatile commodity, and gains now reflect renewed optimism rather than long-term certainty.
Get access to Proactive Equities’ latest high conviction stock picks and trade signals
Our Standard Membership will give you access to
Our Dividend Portfolio
Our Growth Portfolio
High Conviction Buys Now
Sector Reports
Fortnightly Investor webinars
Weekly Macro Insights
Our recommendations feature attractive buy ranges, stop-loss levels, and price targets
Our Premium Membership will give you access to:
Short-term Trading Signals
Our Dividend Portfolio
Our Growth Portfolio
High Conviction Buys Now
Sector Reports
Fortnightly Investor webinars
Weekly Macro Insights